Amylyx Pharmaceuticals, Inc. (AMLX) Reports In-Line Q2 EPS

Amylyx Pharmaceuticals, Inc. (NASDAQ: AMLX) reported Q2 EPS of ($0.46), in-line with the analyst estimate of ($0.46).

For earnings history and earnings-related data on Amylyx Pharmaceuticals, Inc. (AMLX) click here.

You May Also Be Interested In

• Why a solid NFP report could spark a stock selloff, according to JPMorgan
• Atmus Filtration Technologies Inc. (ATMU) Tops Q2 EPS by 7c ; Offers Guidance
• Wendy's (WEN) Tops Q2 EPS by 1c, Reduces Dividend